Status
Acquired by Eisai on January 7, 2010
Funding Received
$26.1 Million in 1 Round from 2 Investors
Founded:
2005
Headquarters:
Paramus, NJ
Description:
AkaRx develops therapeutics including the orally-available small molecule for use in the treatment of thrombocytopenia.
Founders:
Robert E. Desjardins
Categories:
Biotechnology

Detailed Description

Update

AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.

Current Team (1)

Update

Funding Rounds (1) - $26.1M

Update

Investors (2)

Update
  • 6ac59da9b3335d229c3c5b52c0761783

    Sutter Hill Ventures

    Sutter Hill Ventures has financed technology-based start-ups and assisted entrepreneurs in...
  • Bb3d6fbd0e442789b59061f392f8ad0d

    InterWest Partners

    InterWest invests an average of about $7 - 15 million over the span of their involvement with...

Offices/Locations (1)

Update
  • Office

    Mack Centre IV

    4th Floor

    Paramus, NJ 07652

    USA